Cargando…

Identification of Novel Targets for Treatment of Dilated Cardiomyopathy Based on the Ferroptosis and Immune Heterogeneity

PURPOSE: This study aimed to investigate the role of ferroptosis in dilated cardiomyopathy (DCM) and to identify new targets for treatment and diagnosis of DCM. METHODS: GSE116250 and GSE145154 were downloaded from the Gene Expression Omnibus database. Unsupervised consensus clustering of DCM patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Hongyu, Xie, Yun, Zhou, Ziyou, Hong, Peijian, Chen, Jiyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276607/ https://www.ncbi.nlm.nih.gov/pubmed/37334346 http://dx.doi.org/10.2147/JIR.S407588

Ejemplares similares

Ferroptosis, necroptosis and cuproptosis: Novel forms of regulated cell death in diabetic cardiomyopathy
por: Ke, Dan, et al.
Publicado: (2023)

Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy via a Microarray Data Analysis
por: Wang, Zuoxiang, et al.
Publicado: (2022)

Identification and Verification of Feature Biomarkers Associated With Immune Cells in Dilated Cardiomyopathy by Bioinformatics Analysis
por: Zhu, Tingfang, et al.
Publicado: (2022)

Identification and validation of ferroptosis-related genes and immune infiltration in ischemic cardiomyopathy
por: Huang, Kai, et al.
Publicado: (2023)

The Molecular Role of Immune Cells in Dilated Cardiomyopathy
por: Wang, Enping, et al.
Publicado: (2023)

Ferroptosis as a target for protection against cardiomyopathy
por: Fang, Xuexian, et al.
Publicado: (2019)

Identification of a novel variant in N-cadherin associated with dilated cardiomyopathy
por: Chen, Yuanying, et al.
Publicado: (2022)

Identification of BMP10 as a Novel Gene Contributing to Dilated Cardiomyopathy
por: Gu, Jia-Ning, et al.
Publicado: (2023)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Ferroptosis Is a Potential Novel Diagnostic and Therapeutic Target for Patients With Cardiomyopathy
por: Zhai, Zhenyu, et al.
Publicado: (2021)

Identification of key immune-related genes in dilated cardiomyopathy using bioinformatics analysis
por: Li, Feng, et al.
Publicado: (2023)

Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy
por: Yang, Yujiao, et al.
Publicado: (2022)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Targeted next-generation sequencing of candidate genes reveals novel mutations in patients with dilated cardiomyopathy
por: ZHAO, YUE, et al.
Publicado: (2015)

Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses
por: Zhou, Honghua, et al.
Publicado: (2020)

Identification of novel genetic risk factors of dilated cardiomyopathy: from canine to human
por: Niskanen, Julia E., et al.
Publicado: (2023)

Identification of Heparan Sulfate in Dilated Cardiomyopathy by Integrated Bioinformatics Analysis
por: Song, Wenyu, et al.
Publicado: (2022)

Apoptosis in Dilated Cardiomyopathy
por: Hong, Bum Kee, et al.
Publicado: (2000)

Identification of MYLK3 mutations in familial dilated cardiomyopathy
por: Tobita, Takashige, et al.
Publicado: (2017)

The Genetic Evaluation of Dilated Cardiomyopathy
por: Bui, Quan M., et al.
Publicado: (2023)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy
por: Zhao, Lifang, et al.
Publicado: (2018)

Cushing Syndrome in the Setting of Chronic Dilated Cardiomyopathy: Can Treatment Improve Chronic Dilated Cardiomyopathy?
por: Pathak, Leilani, et al.
Publicado: (2021)

Cardiomyopathy, familial dilated
por: Taylor, Matthew RG, et al.
Publicado: (2006)

Dilated cardiomyopathy in childhood
por: Franklin, OM, et al.
Publicado: (2000)

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Publisher Correction: Identification of key immune-related genes in dilated cardiomyopathy using bioinformatics analysis
por: Li, Feng, et al.
Publicado: (2023)

Speckle tracking echocardiography in hypokinetic non‐dilated cardiomyopathy: comparison with dilated cardiomyopathy
por: Mombeini, Hoda, et al.
Publicado: (2020)

Native left ventricular myocardial T(1) spatial heterogeneity in non-ischemic dilated cardiomyopathy
por: Kashem, Abyaad, et al.
Publicado: (2016)

Histopathologic features of alcoholic cardiomyopathy compared with idiopathic dilated cardiomyopathy
por: Li, Xuebiao, et al.
Publicado: (2018)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Pyroptosis Patterns Are Involved in Immune Microenvironment Regulation of Dilated Cardiomyopathy
por: Wang, Kexin, et al.
Publicado: (2022)

The role of Asprosin in patients with dilated cardiomyopathy
por: Wen, Ming-Shien, et al.
Publicado: (2020)

Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy
por: Sun, Huiyan, et al.
Publicado: (2023)

Immune Mechanism, Gene Module, and Molecular Subtype Identification of Astragalus Membranaceus in the Treatment of Dilated Cardiomyopathy: An Integrated Bioinformatics Study
por: Chen, Xiao-yang, et al.
Publicado: (2021)

Rare combination of dilated cardiomyopathy and ankylosing spondylitis in a family
por: Xing, Yun-Li, et al.
Publicado: (2018)

Identification of Immune Markers in Dilated Cardiomyopathies with Heart Failure by Integrated Weighted Gene Coexpression Network Analysis
por: Wang, Xuehua, et al.
Publicado: (2022)

Targeting Ferroptosis for Lung Diseases: Exploring Novel Strategies in Ferroptosis-Associated Mechanisms
por: Ma, Tian-Liang, et al.
Publicado: (2021)

Ferroptosis Related Genes in Ischemic and Idiopathic Cardiomyopathy: Screening for Potential Pharmacological Targets
por: Jiang, Yufeng, et al.
Publicado: (2022)

Hypoparathyroidism and reversible dilated cardiomyopathy
por: Babu, M. Suresh, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vchmhn4oinr6iane6chgtrtdlq